Effects of living near a new urban motorway on the travel behaviour of local residents in deprived areas: Evidence from a natural experimental study
on behalf of the M74 study team,
Health & Place
MetadataShow full item record
Foley, L., Prins, R., Crawford, F., Sahlqvist, S., Ogilvie, D., & on behalf of the M74 study team,. (2017). Effects of living near a new urban motorway on the travel behaviour of local residents in deprived areas: Evidence from a natural experimental study. Health & Place, 43 57-65. https://doi.org/10.1016/j.healthplace.2016.11.008
We evaluated the effects of a new motorway built through deprived neighbourhoods on travel behaviour in residents. This natural experiment comprised a longitudinal cohort (n=365) and two cross-sectional samples (baseline n=980; follow-up n=978) recruited in 2005 and 2013. Adults from one of three study areas - surrounding the new motorway (South), an existing motorway (East), or no motorway (North) - completed a previous day travel record. Adjusted two-part regression models examined associations between exposure and outcome. Compared to the North, cohort participants in the South were more likely to undertake travel by any mode (OR 2.1, 95% CI 1.0-4.2) at follow-up. Within the South study area, cohort participants living closer to a motorway junction were more likely to travel by any mode at follow-up (OR 4.7, 95% CI 1.1-19.7), and cross-sectional participants living closer were more likely to use a car at follow-up (OR 3.4, 95% CI 1.1-10.7), compared to those living further away. Overall, the new motorway appeared to promote travel and car use in those living nearby, but did not influence active travel. This may propagate socioeconomic inequalities in non-car owners.
road, automobiles, active travel, transportation, natural experimental study
LF is supported by the National Institute for Health Research Public Health Research programme (NIHR PHR; project number 11/3005/07) and the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged (087636/Z/08/Z, ES/G007462/1, MR/K023187/1). DO and RP are supported by the Medical Research Council (MC_UU_12015/6). FT is employed in a hybrid role between NHS Greater Glasgow and Clyde and Glasgow Centre for Population Health (GCPH). GCPH is a partnership between NHS Greater Glasgow and Clyde, Glasgow City Council, and the University of Glasgow, funded by the Scottish Government.
NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) (PHR/11/3005/07)
Wellcome Trust (087636/Z/08/Z)
MEDICAL RESEARCH COUNCIL (G106/1203)
Embargo Lift Date
External DOI: https://doi.org/10.1016/j.healthplace.2016.11.008
This record's URL: https://www.repository.cam.ac.uk/handle/1810/261607
Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International